Search - tctmd.com

Displaying 1 - 20 of 31

Sort: Relevancy | Date

News Conference News CX Symposium 2025

Paclitaxel or Sirolimus: New PAD Studies Shed Light on Choices

L.A. McKeown

April 23, 2025

News Conference News VIVA 2024

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

L.A. McKeown

November 05, 2024

News Conference News LINC 2023

Early Data on Temporary Spur in BTK PAD Show Efficacy, Limited Recoil

L.A. McKeown

June 09, 2023

News Daily News

Five-Year Paclitaxel DCB Data Attest to Long-term Safety, Efficacy

L.A. McKeown

June 01, 2022

News Daily News

Vascular Experts Say It’s Time to Let Paclitaxel Out of Regulatory Jail

L.A. McKeown

April 22, 2021

News Conference News LINC 2020

Algorithm Aims to Help Operators Pair Laser Settings With PAD Lesion Type

L.A. McKeown

February 06, 2020

News Conference News VIVA 2019

IN.PACT Global Registry Shows Continued Safety, Efficacy at 4 Years for Paclitaxel DCB

L.A. McKeown

November 05, 2019

News Industry News

Veryan Medical receives PMA approval for BioMimics 3D

October 05, 2018

Presentation VIVA 2017

Two-year Results from the IN.PACT Global Study

Presenter: Thomas Zeller

September 14, 2017

News Conference News VIVA 2017

DCBs, Stents, and ‘Swirling Flow’ Show Promise in Femoropopliteal Disease

L.A. McKeown

September 13, 2017

News Daily News

Potential Benefits of Drug-Coated Balloons for Infrapopliteal Disease Remain Uncertain

Todd Neale

April 28, 2016

News Conference News VEITH 2015

DCBs for Femoropoliteal Disease: What’s Now and What’s Next?

Yael L. Maxwell

November 19, 2015

News Daily News

More Discouraging News for DCBs in Treatment of Infrapopliteal Lesions

L.A. McKeown

October 26, 2015

News Daily News

Más Noticias Desalentadoras para los BRFs en el Tratamiento de Lesiones Infrapoplíteas

L.A. McKeown

October 26, 2015

News Daily News

DCB治疗膝下病变又传出令人失望的消息

L.A. McKeown

October 26, 2015

Presentation

Paclitaxel-Coated Balloon in Infrapopliteal Arteries

Presenter: Thomas Zeller

October 23, 2015

News Industry News

First Subject Enrolled in Veryan Medical's MIMICS-2 Study

July 01, 2015

Presentation TCT 2014

DCB and the Use of Ancillary Devices III: Unmet Technical Needs and Opportunities for Development of Next-Generation Technologies

Presenter: Kenneth Rosenfield, Thomas Zeller, Raghu Kolluri, Arne Schwindt

September 15, 2014

Presentation TCT 2014

DCB and the Use of Ancillary Devices II: Atherectomy - Insights from The DEFINITE AR Trial

Presenter: Kenneth Rosenfield, Thomas Zeller, Raghu Kolluri, Gunnar Tepe

September 15, 2014

Presentation TCT 2014

DCB and the Use of Ancillary Devices I: BMSDCB Interactions Provisional Versus Primary Use?

Presenter: Kenneth Rosenfield, Thomas Zeller, Raghu Kolluri, Francesco Liistro

September 15, 2014

Advertisement

Paclitaxel or Sirolimus: New PAD Studies Shed Light on Choices

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

Early Data on Temporary Spur in BTK PAD Show Efficacy, Limited Recoil

Five-Year Paclitaxel DCB Data Attest to Long-term Safety, Efficacy

Vascular Experts Say It’s Time to Let Paclitaxel Out of Regulatory Jail

Algorithm Aims to Help Operators Pair Laser Settings With PAD Lesion Type

IN.PACT Global Registry Shows Continued Safety, Efficacy at 4 Years for Paclitaxel DCB

Veryan Medical receives PMA approval for BioMimics 3D

Two-year Results from the IN.PACT Global Study

DCBs, Stents, and ‘Swirling Flow’ Show Promise in Femoropopliteal Disease

Potential Benefits of Drug-Coated Balloons for Infrapopliteal Disease Remain Uncertain

DCBs for Femoropoliteal Disease: What’s Now and What’s Next?

More Discouraging News for DCBs in Treatment of Infrapopliteal Lesions

Más Noticias Desalentadoras para los BRFs en el Tratamiento de Lesiones Infrapoplíteas

DCB治疗膝下病变又传出令人失望的消息

Paclitaxel-Coated Balloon in Infrapopliteal Arteries

First Subject Enrolled in Veryan Medical's MIMICS-2 Study

DCB and the Use of Ancillary Devices III: Unmet Technical Needs and Opportunities for Development of Next-Generation Technologies

DCB and the Use of Ancillary Devices II: Atherectomy - Insights from The DEFINITE AR Trial

DCB and the Use of Ancillary Devices I: BMSDCB Interactions Provisional Versus Primary Use?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content